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Abstract Erythroid spectrin is the main component of the red
cell membrane skeleton, which is very important in determining
the shape, resistance to mechanical stresses and deformability of
red cells. Previously we demonstrated that human erythroid
K-spectrin is ubiquitinated in vitro and in vivo, and using
recombinant peptides we identified on repeat 17 the main
ubiquitination site of K-spectrin. In order to identify the lysine(s)
involved in the ubiquitination process, in the present study we
mutated the lysines by site-directed mutagenesis. We found that
ubiquitination was dramatically inhibited in peptides carrying
the mutation of lysine 27 on repeat 17 (mutants K25,27R and
K27R). We also demonstrated that the correct folding of this
protein is fundamental for its recognition by the ubiquitin
conjugating system. Furthermore, the region flanking lysine 27
showed a 75% similarity with the leucine zipper pattern present
in many regulatory proteins. Thus, a new potential ubiquitin
recognition motif was identified in K-spectrin and may be present
in several other proteins. ß 2001 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Ubiquitin is a polypeptide of 76 amino acids, which is
highly conserved and found both free and covalently bound
to target proteins. Conjugation of ubiquitin to the substrate
proceeds via a three-step mechanism. Initially, ubiquitin is
activated in its C-terminal glycine by ATP and the ubiquitin
activating enzyme (E1). Following activation, a ubiquitin con-
jugating enzyme (E2) transfers ubiquitin from E1 to the sub-
strate via a member of the ubiquitin^protein ligase family
(E3). Ubiquitin is usually transferred to an O-amino group
of a Lys residue of the protein substrate to generate an iso-
peptide bond [1]. Within the ubiquitin system, substrates are
recognized by di¡erent E3s or E2/E3 complexes [2]. Some
proteins are recognized via primary signals in their sequence,
while others must undergo post-translational modi¢cations
such as phosphorylation, or associate with other polypeptides
such as molecular chaperones prior to recognition by the ap-
propriate ligase. Multiubiquitination of some proteins deter-
mines their degradation by the 26S-protease complex [3]. In
other cases ubiquitination takes part in functional regulation
of a substrate protein [4,5]. In mature erythrocytes the activity
of the ubiquitin mediated proteolytic system is lost and several
enzymes, in particular the ubiquitin conjugating enzymes (E2),
show a decrease during red blood cell maturation. However,
substantial levels of ubiquitin^protein conjugates persist in
erythrocytes indicating that at least some enzymes capable
of bringing about conjugate formation remain [6].
Previously, we demonstrated that red blood cell K-spectrin
is a speci¢c physiological substrate for ubiquitination [7^9]
and, using recombinant peptides, we found that repeats 17
and 20 are actively ubiquitinated, at least in vitro [10].
Spectrin is the main constituent of the erythrocyte mem-
brane skeleton and represents about 25% in weight of the
total red cell membrane proteins [11]. Spectrin is composed
of two elongated subunits, K and L chains (280 and 246 kDa,
respectively), non-covalently associated side-to-side in an anti-
parallel orientation to form heterodimers [12]. Spectrin heter-
odimers associate head-to-head to form tetramers, which in
turn constitute the long, £exible ¢laments of the network.
Spectrin also forms non-covalent associations with other pro-
teins of the erythrocyte skeleton, such as ankyrin, band 4.1
[13], actin, adducin and tropomyosin [14,15]. The K-spectrin
chain consists of 22 repeating segments, whereas the L-spec-
trin chain consists of only 17 repeats. The repeating segments
of K-spectrin, which are about 106 amino acids long, show
sequence identity of about 20% but some residues are highly
conserved, notably leucine and tryptophan at positions 26 and
45 of the repeats [13,15]. Recombinant DNA techniques have
been used to produce fragments of spectrin that can serve as
models for the native protein. A number of di¡erent spectrin
fragments from several species and tissues have already been
prepared and investigated by various techniques [16^18]. The
¢rst detailed structural model for one spectrin repeat unit was
based on the X-ray crystal structure of the 14th segment of
Drosophila K-spectrin, which revealed three helices (A, B and
C) aligned side by side, with helices A and C parallel and helix
B antiparallel [19]. More recent structural models of two con-
nected repeats of chicken brain K-spectrin revealed that the
helices C and A of adjacent units are connected by a linker
region, which is K-helical [20].
In a previous study we used di¡erent recombinant peptides
to determine which repeats within the K-spectrin chain are
ubiquitinated. Peptide K16^17 (containing the entire repeat
17 and part of repeats 16 and 18 of K-spectrin) was the short-
est highly ubiquitinated peptide identi¢ed in in vitro assays. In
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the present study we used site-directed mutagenesis techniques
to search for the lysine(s) directly involved in ubiquitin bind-
ing on this molecule in order to localize the structural motif
involved in the recognition of K-spectrin by the E2s^E3s en-
zymes.
Interestingly, the identi¢ed sequence is 75% similar to a
pattern present in many regulatory proteins and thus could
represent a new recognition site for protein ubiquitination and
turnover.
2. Materials and methods
2.1. Materials
Pfu DNA polymerase was from Stratagene. Restriction enzymes
were from Gibco-BRL. Bacterial strain JM 109 was from Promega.
The glutathione^Sepharose 4B a⁄nity column was from Amersham
Pharmacia Biotech. All other chemicals were purchased from Sigma.
2.2. Construction of the wild type peptides
Recombinant cDNA encoding K-spectrin fragment K16^17 was ob-
tained by polymerase chain reaction (PCR) ampli¢cation of human K-
spectrin cDNA clone K14^17, kindly provided by D.W. Speicher
(Wistar Institute, Philadelphia, PA, USA). Pfu DNA polymerase
was used under standard conditions in the PCR [21]. The oligonucleo-
tide primers used for cDNA ampli¢cation were 5P-GGGGGAATTC-
TAAAGCTCAATGAGGCCAGTCG-3P (forward primer) and 5P-
GGGGCCATGGTTATAGGGATTCTTCCAACTTAAG-3P (reverse
primer). Three small recombinant cDNA sequences were sub-cloned
by PCR ampli¢cation from clone K16^17. These sequences coded for
three peptides referred to as A, B and C, respectively, from L13 to
D41, from L18 to F36 and from H22 to L32, according to the amino
acid sequence of K-spectrin repeat 17 (Table 1). The oligonucleotide
primers used for cDNA ampli¢cation were: peptide A, 5P-AAGC-
GAATTCTGAATGTCCAAGA-3P (forward primer) and 5P-TCCAC-
CATGGTTAATCATCTAGATCCTGG-3P (reverse primer); peptide
B, 5P-GTCCGAATTCTGGCAGCTGCACAC-3P (forward primer)
and 5P-CATCCCATGGTTAGAAGAACTGGAACAAGG-3P (re-
verse primer); peptide C, 5P-GCAGGAATTCACCACGAAAAATT-
GAA-3P (forward primer) and 5P-GGAACCATGGTTACAAGGCA-
TAGGCC3P (reverse primer). All the primers contained restriction
enzyme sites for EcoRI (forward primers) and NcoI (reverse primers)
(underlined sequences). The restriction sites in the reverse primers
were preceded by a stop codon. The puri¢ed PCR ampli¢ed DNAs
were cut with the appropriate enzymes and directionally cloned into
the restricted pGEX-KG vector [22] using standard techniques. Trans-
formation was performed in Escherichia coli strain JM 109. The reli-
ability of the PCR reactions was subsequently con¢rmed by direct
DNA sequencing and the peptides were expressed as glutathione-S-
transferase (GST) fusion protein.
2.3. Site-directed mutagenesis
Mutations were introduced in the K16^17 construct according to
the site-directed mutagenesis method known as long primer unique
site elimination (LP-USE) mutagenesis [23] and modi¢ed as previously
described [24]. Mutations were introduced using two kinds of mutant
primers: (i) the selection primer (forward primer) GGTTCC-
GCGTGGTACCCCGGGAATTTCC, which eliminates the unique
BamHI site by converting it into a KpnI site (underlined sequence);
(ii) the other primers (reverse primers) contained the desired muta-
tions (Table 2). A total of 10 recombinant peptides containing
16 mutated lysines were produced for this study. All clones were
sequenced to verify the presence of the mismatched bases and the
¢delity of the remaining sequence.
2.4. Expression and puri¢cation of wild type or mutant peptides
Overnight cultures were diluted 1:15 in Terri¢c Broth medium con-
taining 100 Wg/ml ampicillin and grown at 37‡C to an optical density
of 0.5^0.7 at 600 nm. The cultures were diluted again 4:5 and incu-
bated for a further 15 min before induction with 0.5 mM isopropyl
L-D-thiogalactopyranoside. Cells were induced for 2 h. After centrifu-
gation the bacterial pellets were frozen and stored at 320‡C. GST
fusion proteins were puri¢ed as described previously [25]. Brie£y, cell
pellets from 1 l of culture were resuspended in 30 ml of 20 mM
phosphate bu¡er pH 7.3, 150 mM NaCl, 1% Triton X-100, containing
1 mM EDTA, 0.5 mM 4-(2-aminoethyl)benzenesulfonyl £uoride
(AEBSF) or phenylmethylsulfonyl £uoride (PMSF), 2 Wg/ml leupep-
tin, 2 Wg/ml pepstatin, 100 U/ml aprotinin, 1 mM L-mercaptoethanol
and lyzed by sonication. After centrifugation, the cleared lysates were
loaded onto a reduced glutathione^Sepharose 4B column. GST fusion
proteins were eluted with 50 mM Tris pH 8.0 containing 10 mM
glutathione.
2.5. Ubiquitin conjugation assays
Ubiquitin conjugation assays were performed essentially as de-
scribed [7] with slight modi¢cations. In a ¢nal volume of 30 Wl, the
reaction mixture contained 80 mM Tris pH 7.6, 4 mM MgCl2, 1 mM
dithiothreitol, 3.5 mM ATP, 14 mM creatine phosphate, 2.2 Wg of
creatine phosphokinase, 13 Wg of fraction II, 5 WM 125I-Ub, 1 mM
PMSF, 1 mM AEBSF, 1 WM leupeptin, 1 WM pepstatin and 50 pmol
of puri¢ed GST fusion protein. Following 1 h of incubation at 37‡C,
the mixture was boiled for 3 min in Laemmli sample bu¡er containing
2% L-mercaptoethanol and then electrophoresed by SDS^PAGE. Gels
were stained, dried and autoradiographed.
2.6. Other procedures
SDS^PAGE was performed as described by Laemmli [26]. Gels
were stained with Coomassie Brilliant Blue R-250. Protein concentra-
tions were determined by absorbancy at 280 nm using extinction co-
e⁄cients calculated from sequences. Alternatively, protein concentra-
tions were determined by the method of Bradford [27]. Quantitative
Table 1
Amino acid sequence of peptides A, B and C
Peptide Amino acid sequence
A LNVQELAAAHHEKLKEAYALFQFFQDLDD
B LAAAHHEKLKEAYALFQFF
C HHEKLKEAYAL
Lysine 27 is in bold.
Table 2
Design of mutant recombinant GSTK16^17 peptides
Repeat Mutations Mutated reverse primers
17 K3,4,5R GTTGACATTATCTCTTCTCCTCACAATCTGATC
17 K25R GGCCTCTTTCAATCTTTCGTGGTGTGCAG
17 K27R GGCATAGGCCTCTCTCAATTTTTCGTGG
17 K25,27R GGCATAGGCCTCTCTCAATCTTTCGTGGTGTGCAG
17 K49R CACTCGTATCAACCTCTCCTCTATCCAG
17 K70,71,73R CCCCTCTAGGCGTCTGTGCCTCCTCAGCAAGTTCTGAACC
17 K95,97,99R CCCCACAGCAGCCCTGTCTCTCAGCCTCTCTGCCATATCC
18 K14,16R CCTTGGCCAACTCTCTGAGCCTCTCCCAGTGTTC
18 K50R AGTCCTCGGGCCCTGGCCAACTCTTTG
18 K25R GGGATTCTTCCAACCTAAGTCCTCGGGC
Lysines 3, 4, 5, 25, 27, 49, 70, 71, 73, 95, 97 and 99 on repeat 17 and lysines 14, 16, 20 and 25 on repeat 18 correspond, respectively, to lysines
1685, 1686, 1687, 1707, 1709, 1731, 1752, 1753, 1755, 1777, 1779, 1781, 1802, 1804, 1808 and 1813 on the entire K-spectrin sequence.
Mutated nucleotides are in bold.
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determinations of protein bands in Coomassie Blue stained gels were
performed using an LKB Ultroscan XL laser densitometer. The gels
(stained and dried) were also analyzed with a GS-250 Molecular Im-
ager (BioRad) to evaluate the radioactivity incorporated into the
GSTK16^17 mutant peptides.
3. Results
3.1. Expression and puri¢cation of wild type and mutant
K-spectrin peptides
In a previous study we constructed the recombinant K16^17
peptide as a reliable model of the entire K-spectrin [10]. The
recombinant peptide K16^17 includes a region of K-spectrin
ranging from lysine 25 of repeat 16 (K1601) to leucine 30 of
repeat 18 (L1818), according to the published human K-spec-
trin sequence [28]. Moreover, this peptide is formed by two
homologous conformational units which allow it to fold cor-
rectly and as a stable structure [16]. In this study we con-
structed ten mutants in an attempt to identify the lysine(s)
involved in ubiquitin conjugation. The GSTK16^17 wild
type or mutant peptides were highly expressed and soluble
in bacteria, but di¡ered slightly in their yield. Yields of the
puri¢ed fusion proteins ranged from 20 mg/l of bacterial cul-
ture for wild type GSTK16^17, to 5 mg/l for mutant
17K70,71,73R. Peptides A, B and C were fragments of the
K-spectrin repeat 17 (see below). Although the yields of these
peptides were comparable to those of wild type GSTK16^17
peptide, it is likely that they did not fold correctly in the K
helix structure because they represent only a part of the re-
petitive unit. After elution from the glutathione^Sepharose 4B
a⁄nity column, all of the peptides had an apparent molecular
mass in SDS^PAGE in agreement with the calculated value.
Gel scan analysis of band intensities indicated that the sam-
ples were between 55 and 85% pure. The peptides were uti-
lized in ubiquitin conjugation assays without other puri¢ca-
tion step.
3.2. Identi¢cation of lysines susceptible to ubiquitination on
GSTK16^17
We had previously shown that the GSTK16^17 peptide
could be ubiquitinated, whereas GSTK15^16 and GSTK17
could not. Since ubiquitin binds to proteins via lysine resi-
dues, we used site-directed mutagenesis to substitute lysines
potentially involved in the ubiquitination of the GSTK16^17
peptide. Spectrin fragment K16^17 contains 22 lysines, the
¢rst ¢ve of which were not, however, considered potential
targets for ubiquitin conjugation because they are located in
repeat 16, which is entirely included in the non-ubiquitinated
GSTK15^16 peptide [10]. Therefore, we considered that
GSTK16^17 peptide contained lysines potentially susceptible
to ubiquitination in repeat 17 at positions 3, 4, 5, 10, 25, 27,
49, 70, 71, 73, 95, 97, 99 and in repeat 18 at positions 14, 16,
20, 25 according to the published human K-spectrin sequence
[28]. Comparison of the sequences of mouse and human
erythrocyte K-spectrin revealed conserved lysines in repeat
17 at positions 4, 25, 27, 49, 70, 71, 73 and 99 and in repeat
18 at positions 14, 16 and 20. Despite the fact that non-ubiq-
uitinated GSTK17 peptide contained lysines 25^99 in repeat
17 and lysines 14^25 in repeat 18 [10], we mutated all of the
lysines to arginines, with the exception of lysine 10, either
individually or in groups when clustered close together. Argi-
nine was chosen so as not to change the charge of the protein.
The mutants generated are as indicated in Fig. 1 and Table 2.
Next, we investigated the e¡ects of the Lys to Arg mutations
on the ubiquitination of the GSTK16^17 peptide. Ubiquitina-
tion assays were performed as described in Section 2. 125I-Ub
incorporation in GSTK16^17 wild type and mutant peptides
was quanti¢ed using a Molecular Imager. The counts were
normalized with the real contents of proteins in the Coomas-
sie stained gel before comparison. In all experiments the ubiq-
uitination level of wild type GSTK16^17 was taken as 100%.
In a ¢rst series of experiments this level of ubiquitination was
not signi¢cantly a¡ected by mutations on lysines 3, 4, 5, 49,
Fig. 1. Partial amino acid sequence of wild type GSTK16^17 peptide and the mutant peptides produced for this study. The sequence starts at
the beginning of repeat 17 and stops at the end of the peptide (Leu 30 of repeat 18 according to the published human K-spectrin sequence).
Hyphens indicate unchanged residues.
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70, 71, 73, 95, 97 and 99 in repeat 17 (mutants K3,4,5R,
K49R, K70,71,73R and K95,97,99R) and on lysines 14, 16,
20 and 25 in repeat 18 (mutants K14,16R, K20R and K25R).
In contrast, replacement of lysines 25 and 27 together in re-
peat 17 with arginines (mutants K25,27R) markedly attenu-
ated the conjugation of 125I-ubiquitin on the GSTK16^17 pep-
tide (Fig. 2). Subsequently we mutated lysines 25 and 27
separately in order to determine whether ubiquitination re-
quired one speci¢c lysine or both. Mutant K25R was ubiqui-
tinated in the same way as the wild type, whereas mutant
K27R was much less ubiquitinated. These ¢ndings indicate
that lysine 27 serves as the primary Ub acceptor of K-spectrin
repeat 17. In order to de¢ne the repeat 17 primary sequence
involved in the E2/E3 recognition, we constructed three small
peptides, referred to as A, B and C, respectively, consisting of
a sequence of 29, 19 and 11 amino acids on repeat 17. Each
sequence contained lysine 27 at its center. The ubiquitination
assay using these peptides as substrate showed no evidence of
ubiquitin binding, indicating that the secondary structure of
K-spectrin is very important for the interaction with the enzy-
matic system of ubiquitin conjugation.
3.3. Sequence homology of the K-spectrin ubiquitination site
In an attempt to ¢nd some protein patterns homologous to
the region £anking lysine 27, we searched the PROSITE data-
base using PROSCAN. A search with a 30 amino acid se-
quence containing lysine 27 gave some similarities to various
protein patterns. The most interesting was a 75% similarity of
the K-spectrin fragment LAAAHHEKLKEAYALFQFFQDL
(lysine 27 is underlined) with the leucine zipper pattern.
4. Discussion
Although the enzymatic pathway for ubiquitin conjugation
is well characterized, the way in which proteins are selected
for ubiquitination is only beginning to be clari¢ed. In addition
to providing a lysine residue(s) which can be ubiquitinated,
the substrate proteins contain elements that are targeted di-
rectly by the ubiquitination apparatus, which in most cases is
expected to be a speci¢c E2/E3 complex [2]. In the present
study we have demonstrated a critical requirement for the
presence of lysine 27 of repeat 17 for ubiquitination of human
erythroid K-spectrin recombinant peptide. Although ubiquiti-
nation was dramatically inhibited in mutant K25,27R and
K27R, it appears not to be totally abrogated (see Fig. 2).
This fact may be explained with two hypotheses: (i) ubiquiti-
nation can also occur at other sites, albeit much less e⁄ciently
and (ii) endogenous AGA codons or other AGA codons in-
troduced by mutagenesis are subject to low frequency misin-
corporation of lysine for arginine in E. coli, as previously
described by You et al. [29]. The presence of lysine 27 of
repeat 17 in recombinant peptides is not su⁄cient to promote
ubiquitin conjugation. In fact, peptides GSTK15^16 and
GSTK17 contained this lysine but were not ubiquitinated
Fig. 2. Ubiquitination of wild type GSTK16^17 or mutant
GSTK16^17 peptides. The mutant peptides were tested in ubiquitin
conjugation assays as described in Section 2. The ubiquitination of
the mutant peptides is shown as a percent of wild type GSTK16^17.
The values are the means of several independent experiments þ S.D.
Fig. 3. Comparison of sequences of K-spectrin repeat 17. Erythroid and non-erythroid K-spectrin of di¡erent species with known sequences are
compared. ‘*’ indicates perfect matches and ‘:’ indicates a high similarity between the sequences. Lysine 27 in the human sequence is under-
lined.
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[10]. These data indicate that some amino acid residues £ank-
ing this lysine are necessary for recognition of the substrate
and subsequent ubiquitination. In an attempt to de¢ne the
sequence £anking lysine 27 involved in the conjugation pro-
cess, we constructed three smaller peptides (A, B and C) con-
taining this lysine in the middle of their sequence. These pep-
tides were only part of repeat 17 and we expected that their
secondary structure would be lost or severely compromised, as
described by Winograd et al. [17]. None of these peptides were
ubiquitinated in vitro, suggesting that not only the primary
sequence is important in the recognition of K-spectrin by the
enzymatic system of ubiquitin conjugation but also the correct
folding of the molecule. Lysine 27 is located in a region be-
tween helices C and A of the triple helical structure of the
repetitive unit. In the crystal structure, helices C and A ap-
peared to be uninterrupted [20]. In solution, however, the
£exibility between segments appears to involve some disrup-
tion of this continuous helix [30]. Recent hydrodynamic stud-
ies of human erythroid K-spectrin fragments support the hy-
pothesis that there is a £exible and non-helical linking region
between rigid segments [31]. Lysine 27 is located in this region
and it could be interesting to verify the involvement of ubiq-
uitination in regulating the £exibility of the molecule. Inter-
estingly, comparison (using the LALIGN program) between a
30 amino acid sequence £anking this lysine and the entire K-
spectrin sequence showed an identity of 36.7% with the ho-
mologous part of repeat 20, probably the second locus of
ubiquitination, as we shown previously [10]. In all repetitive
units of K-spectrin, lysine 27 is present only in repeats 17 and
6 but in this case the identity of sequences £anking this lysine
was only 30%. Sequence comparison of non-erythroid and
erythroid repeat 17 K-spectrins of di¡erent species showed
low similarity in the region containing lysine 27 (Fig. 3). In
fact, in this region only human and mouse erythroid K-spec-
trin can be considered very homologous (about 93% identity).
Interestingly, mouse K-spectrin is also ubiquitinated in vitro
(not shown). Moreover, in Drosophila K-spectrin and in non-
erythroid spectrins, lysine 27 is not present. Previously we had
shown that non-erythroid chicken K-spectrin was not ubiqui-
tinated in vitro [8] and our current data may explain this
¢nding. In conclusion, the data presented seem to indicate
that there is no strict sequence consensus motif for ubiquiti-
nation in K-spectrin but rather a conformational recognition
mechanism where the position of a critical lysine seems to be
important.
A further sequence homology search of the K-spectrin ubiq-
uitination site identi¢ed a similarity with the leucine zipper
pattern. The leucine zipper consists of a periodic repetition
of leucine residues at every seventh position. The segments
containing these periodic arrays of leucine residues seem to
exist in an K-helical conformation. The leucine zipper pattern
is present in many gene regulatory proteins, many of which,
curiously, are ubiquitinated [32]. In particular c-jun could be
ubiquitinated in this region [33]. Such similarities may indicate
certain homologies in parts of sequences of completely di¡er-
ent ubiquitinated proteins.
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